Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Accounts Payables (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Accounts Payables for 4 consecutive years, with $761901.0 as the latest value for Q4 2025.

  • Quarterly Accounts Payables fell 22.83% to $761901.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $761901.0 through Dec 2025, down 22.83% year-over-year, with the annual reading at $761901.0 for FY2025, 22.83% down from the prior year.
  • Accounts Payables for Q4 2025 was $761901.0 at bioAffinity Technologies, down from $940761.0 in the prior quarter.
  • The five-year high for Accounts Payables was $1.4 million in Q1 2025, with the low at $146537.0 in Q1 2023.
  • Average Accounts Payables over 4 years is $678890.4, with a median of $772419.0 recorded in 2024.
  • The sharpest move saw Accounts Payables surged 452.09% in 2023, then dropped 22.83% in 2025.
  • Over 4 years, Accounts Payables stood at $345042.0 in 2022, then surged by 75.28% to $604789.0 in 2023, then soared by 63.25% to $987311.0 in 2024, then dropped by 22.83% to $761901.0 in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $761901.0, $940761.0, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.